Delivery Order SPE2DB22D2206-SPE2DB25FHB17
Award Date
5/20/25
Potential Completion Date
5/21/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,798.78 firm-fixed-price contract is for the delivery of 100 tablets of 27 mg extended-release methylphenidate, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a completion date of July 2, 2024. This delivery order is part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,273.72 firm-fixed-price contract is for the delivery of 36 mg methylphenidate extended-release tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,867.90 firm-fixed-price delivery order is for the supply of 100 tablets of 18 mg Methylphenidate Extended Release, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 7, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite...
This is a $1,379.20 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of methylphenidate extended-release 36 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of April 9, 2025 and was awarded on April 8, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,293.70 firm-fixed-price contract is for the delivery of 100 tablets of 27 mg methylphenidate extended-release, a drug used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 54mg methylphenidate extended-release tablets. The contract has a ceiling value of $4,189.21 and a period of performance through April 18, 2025. It is a firm-fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,414.83, is for the delivery of 18 mg extended-release methylphenidate tablets, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a period of performance through October 24, 2024 and is structured as a firm fixed-price...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,564,555,891 tablets of 27 mg extended-release methylphenidate, a controlled substance used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $4,199.16 and an ultimate completion date of May 10, 2024. It is a firm fixed-price contract, awarded without any...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,888.03, is for the delivery of 54 mg Methylphenidate Extended Release (ER) tablets, a medication commonly used to treat Attention Deficit Hyperactivity Disorder (ADHD). The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,923.35 and is for the procurement of 100 tablets of Methylphenidate ER 36 mg, which is a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract has a firm fixed price pricing type and a period of performance through May 22, 2024. The contract is...